PAR

1.92%

25.5¢ paradigm biopharmaceuticals limited..

Hoping your scenario 1 comes into play. I agree that FDA likely...

First 2 Last

Share
Profile

Follow
Polorot

47 Posts.

2

21/07/21

12:43

Post #: 54658816
Share

Originally posted by Axlerod: ↑

My prediction is that the FDA will use all 30 days to respond and PAR will likely receive the FDA response on Friday night July 30th our time with a likely ASX announcement date being Monday August 2nd.

As has been posted by others on this forum I think there are 3 possible announcement scenarios:

Scenario 1. The agency advises that the IND status is now Open

Scenario 2. The agency has a minor query concerning PARs response submitted on June 30th. Such a query would presumably be able to be responded to without too much additional delay.

Scenario 3. The agency advises that they still have outstanding concerns which have not been resolved by PARs June 30th responses. It becomes apparent to the company that the outstanding concerns are best resolved by an additional non-clinical study. An additional study would likely delay our IND opening by potentially a number of months.

Based on my views I have assigned estimated probabilities for the occurrence of each of three scenarios as follows:

Scenario 1. 75%
Scenario 2. 15%
Scenario 3. 10%

I am also speculating a SP movement at the end of trading on the day of the announcement for scenarios 1 and 3 as:

Scenario 1 +40% or $2.80 based on $2 opening price
Scenario 3 -30% or $1.40

I think scenario 2 will result in a SP movement somewhere between Scenario 1 and 3.

Obviously I would expect the SP to trade much higher as we progress through Phase 3.

I am long term holder and still think the company will succeed even if scenario 3 is the outcome at the end of the month.

What does everyone else think in terms of end of day SP for scenarios 1 and 3?

As always DYOR and good luck to us all

Expand

Hoping your scenario 1 comes into play. I agree that FDA likely to respond last minute.
I like your bullish outlook for price after IND green light. My price projection is around $2.45 and around $1.70 if further hold ups come to pass.

PAR Price at posting: $1.97 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

LRV

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

SVL

Silver Mines models five new calderas close to 396Moz Bowdens deposit

LU7

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

SS1

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

RCE

Recce's R327 found effective against E.coli during clinical trial

AVA

Ava Risk Group expands US presence with A$0.7M Substation Deal

CMX

ChemX Materials kicks off first stage works at WA high purity alumina pilot

There are more pages in this discussion • 14 more messages in this thread...

First 2 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 25.5¢		Change -0.005(1.92%)		Mkt cap ! $89.19M

Open	High	Low	Value	Volume
27.0¢	27.0¢	25.5¢	$261.4K	990.7K

Buyers (Bids)

No.	Vol.	Price($)
1	9999	25.5¢

Sellers (Offers)

Price($)	Vol.	No.
26.0¢	9445	1

View Market Depth

No.	Vol.	Price($)
1	9999	0.255
5	259000	0.250
4	96000	0.245
9	261374	0.240
5	71970	0.235

Price($)	Vol.	No.
0.260	9445	1
0.275	44000	2
0.280	35900	3
0.285	6729	2
0.290	60000	2

Last trade - 16.10pm 28/06/2024 (20 minute delay)

PAR (ASX) Chart

Hoping your scenario 1 comes into play. I agree that FDA likely...

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Hoping your scenario 1 comes into play. I agree that FDA likely...

Top Stories

Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%

Silver Mines models five new calderas close to 396Moz Bowdens deposit

Lithium Universe (ASX:LU7) board visits Quebec to engage key stakeholders

Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom

Sun Silver gets that drill to thrill feeling from high grade hits at Maverick Spring

Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker

Microcap Wrap: 5 explorers with news out today

Recce's R327 found effective against E.coli during clinical trial

Ava Risk Group expands US presence with A$0.7M Substation Deal

ChemX Materials kicks off first stage works at WA high purity alumina pilot

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News